Endoscopic ultrasound-guided hepaticogastrostomy and endoscopic retrograde cholangiopancreatography-guided biliary drainage for distal malignant biliary obstruction due to pancreatic cancer with asymptomatic duodenal invasion: a retrospective, single-center study in Japan
Authors:
- Naminatsu TakaharaNaminatsu Takahara
- Yousuke NakaiYNYousuke Nakai
- Kensaku NoguchiKNKensaku Noguchi
- Tatsunori SuzukiTSTatsunori Suzuki
- Tatsuya SatoTSTatsuya Sato
- Ryunosuke HakutaRHRyunosuke Hakuta
- Kazunaga IshigakiKIKazunaga Ishigaki
- Tomotaka SaitoTSTomotaka Saito
- Tsuyoshi HamadaTHTsuyoshi Hamada
- Mitsuhiro FujishiroMFMitsuhiro Fujishiro
Open Access
- 30 January 2025
- journal article
- research article
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 58 (1) , 134-143
Abstract
Background/Aims: Duodenal invasion (DI) is a risk factor for early recurrent biliary obstruction (RBO) in endoscopic retrograde cholangiopancreatography-guided biliary drainage (ERCP-BD). Endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) may reduce early RBO in cases of asymptomatic DI, even when ERCP is possible.Methods: We enrolled 56 patients with pancreatic cancer and asymptomatic DI who underwent EUS-HGS (n=25) or ERCP-BD (n=31). Technical and clinical success, early (<3 months) and overall RBO rates, time to RBO (TRBO), and adverse events were compared between the EUS-HGS and ERCP-BD groups. Risk factors for early RBO were also evaluated.Results: Baseline characteristics were similar between the groups. Both procedures demonstrated 100% technical and clinical success rates, with a similar incidence of adverse events (48% vs. 39%, p=0.59). While the median TRBO was comparable (5.7 vs. 8.8 months, p=0.60), EUS-HGS was associated with a lower incidence of early RBO compared to ERCP-BD (8% vs. 29%, p=0.09). The major causes of early RBO in ERCP-BD were sludge and food impaction, rarely occurring in EUS-HGS. EUS-HGS was potentially reduced early RBO (odds ratio, 0.32; p=0.07).Conclusions: EUS-HGS can be a viable option for treating pancreatic cancer with asymptomatic DI.Keywords
This publication has 30 references indexed in Scilit:
- Usefulness of the laser‐cut, fully covered, self‐expandable metallic stent for endoscopic ultrasound‐guided hepaticogastrostomyJournal of Hepato-Biliary-Pancreatic Sciences, 2022
- Bile aspiration during EUS-guided hepaticogastrostomy is associated with lower risk of postprocedural adverse events: a retrospective single-center studySurgical Endoscopy, 2021
- ERCP-related perforations: a population-based study of incidence, mortality, and risk factorsSurgical Endoscopy, 2019
- Feasibility and Safety of Endoscopic Ultrasound-Guided Biliary Drainage (EUS-BD) for Malignant Biliary Obstruction Associated with Ascites: Results of a Pilot StudyJournal of Gastrointestinal Surgery, 2018
- Similar Efficacies of Endoscopic Ultrasound–guided Transmural and Percutaneous Drainage for Malignant Distal Biliary ObstructionClinical Gastroenterology and Hepatology, 2016
- Transmural Biliary Drainage Can Be an Alternative to Transpapillary Drainage in Patients with an Indwelling Duodenal StentDigestive Diseases and Sciences, 2014
- Multicenter retrospective study of endoscopic ultrasound-guided biliary drainage for malignant biliary obstruction in JapanJournal of Hepato-Biliary-Pancreatic Sciences, 2013
- Duodenal metal stent placement is a risk factor for biliary metal stent dysfunction: an analysis using a time-dependent covariateSurgical Endoscopy, 2012
- Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancerGastrointestinal Endoscopy, 2011
- A lexicon for endoscopic adverse events: report of an ASGE workshopGastrointestinal Endoscopy, 2010